Literature DB >> 16197867

Outcome of laparoscopic cholecystectomy in acute cholecystitis.

Saleh M Al Salamah1.   

Abstract

OBJECTIVE: To evaluate the outcome of laparoscopic cholecystectomy in acute cholecystitis and to determine various pre-operative risk factors predicting conversion to open cholecystectomy.
DESIGN: Observational study. PLACE AND DURATION OF STUDY: Department of Surgery, Riyadh Medical Complex, Riyadh, Saudi Arabia over 5 years period from June 1, 1997 to May 30, 2002. PATIENTS AND METHODS: Consecutive patients admitted with clinical diagnosis of acute cholecystitis confirmed subsequently by abdominal ultrasonography and undergoing laparoscopic cholecystectomy during the same admission. Patients with symptoms of more than one week duration, or various uncontrolled co-morbid conditions requiring optimization before surgery were excluded. Parameters analyzed were morbidity, mortality, incidence and etiology of conversion. Various pre-operative risk factors predicting failure of laparoscopic procedure in acute cholecystitis were further analyzed. Statistical analyses were carried out employing Chi-square test, using IBM-compatible PC, utilizing SPSS 10.0 for Windows (SPSS Inc., Chicago).
RESULTS: Three hundred and eleven patients qualified the inclusion criteria. Mean age was 43.7 years with female to male ratio of 4.5:1. Majority of the patients (91%) were operated within 72 hours of onset of symptoms. Laparoscopic cholecystectomy was successfully accomplished in 86.8 % cases. Out of the 41 converted cases, disturbed anatomy in the region of Calot's triangle was the most common cause of conversion observed in 41.5% patients. Male gender, age more than 65 years, very high leucocyte count, gallbladder wall thickness of more than 4 mm on ultrasonography and complicated disease were observed as most significant determinant for conversion to open procedure. Overall morbidity was 2.9% with no mortality.
CONCLUSION: Laparoscopic cholecystectomy can be accomplished with minimal morbidity in acute cholecystitis. Knowledge of various factors predicting possible conversion helps in pre-operative selection and counseling for open procedure and early conversion to open technique, with further reduction in the overall morbidity of laparoscopic cholecystectomy.

Entities:  

Mesh:

Year:  2005        PMID: 16197867     DOI: 07.2005/JCPSP.400403

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  SAGES guidelines for the clinical application of laparoscopic biliary tract surgery.

Authors:  D Wayne Overby; Keith N Apelgren; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2010-08-13       Impact factor: 4.584

2.  Laparoscopic subtotal cholecystectomy as an alternative procedure designed to prevent bile duct injury: experience of a hospital in northern China.

Authors:  Yu Tian; Shuo-Dong Wu; Yang Su; Jing Kong; Hong Yu; Ying Fan
Journal:  Surg Today       Date:  2009-05-27       Impact factor: 2.549

3.  Laparoscopic cholecystectomy in empyema of gall bladder: An experience at Liaquat University Hospital, Jamshoro, Pakistan.

Authors:  Arshad Malik; Abdul Aziz Laghari; K Altaf Hussain Talpur; Aisha Memon; Qasim Mallah; Jan Mohammad Memon
Journal:  J Minim Access Surg       Date:  2007-04       Impact factor: 1.407

4.  Comparison of early and delayed laparoscopic cholecystectomy for acute cholecystitis: experience from a single center.

Authors:  Rouf Gul; Rayees Ahmad Dar; Riyaz Ahmad Sheikh; Nazir Ahmad Salroo; Adnan Rashid Matoo; Sabiya Hamid Wani
Journal:  N Am J Med Sci       Date:  2013-07

5.  Early vs. Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis - Single Center Experience.

Authors:  Goran Janjic; Milan Simatovic; Velimir Skrbic; Reuf Karabeg; Dragan Radulj
Journal:  Med Arch       Date:  2020-02

6.  Cholecystomucoclasis: revaluation of safety and validity in aged populations.

Authors:  Tomoya Tsukada; Tatsuo Nakano; Takashi Miyata; Shozo Sasaki; Tetsuo Ohta
Journal:  BMC Gastroenterol       Date:  2012-08-21       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.